Bone morphogenetic protein-derived peptide promotes chondrogenic differentiation of human mesenchymal stem cells

Tissue Engineering - Part A

Volumn 18, Issue 23-24, 2012, Pages 2581-2589

  Renner, Julie N ^a   Kim, Yeji ^a   Liu, Julie C ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL DATA; BONE MORPHOGENETIC PROTEIN-2; CARTILAGE TISSUE ENGINEERING; CHONDROGENESIS; CHONDROGENIC DIFFERENTIATION; CULTURE SYSTEMS; DNA CONTENT; GLYCOSAMINOGLYCANS; GROWTH FACTOR; HIGH-THROUGHPUT; HUMAN MESENCHYMAL STEM CELLS; TYPE X COLLAGEN;

CARTILAGE; COLLAGEN; FLOWCHARTING; GENE EXPRESSION; PEPTIDES; PHOSPHATASES; STEM CELLS; TISSUE ENGINEERING;

CELL CULTURE;

ALKALINE PHOSPHATASE; ALPL PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; GLYCOSAMINOGLYCAN; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHONDROGENESIS; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HYPERTROPHY; MESENCHYMAL STROMA CELL; MOLECULAR GENETICS; STIMULATION; SYNTHESIS;

ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; CHONDROGENESIS; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GLYCOSAMINOGLYCANS; HUMANS; HYPERTROPHY; MESENCHYMAL STROMAL CELLS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STIMULATION, CHEMICAL;

EID: 84869817786     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0400     Document Type: Article

References (43)

1. Vinatier, C., Mrugala, D., Jorgensen, C., Guicheux, J., and Noel, D. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 27, 307, 2009.
2. Puetzer, J.L., Petitte, J.N., and Loboa, E.G. Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. Tissue Eng Part B-Rev 16, 435, 2010.
3. Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., and Pittenger, M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4, 415, 1998.
4. Barry, F., Boynton, R.E., Liu, B.S., and Murphy, J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
5. Bouffi, C., Thomas, O., Bony, C., Giteau, A., Venier-Julienne, M.C., Jorgensen, C., Montero-Menei, C., and Noel, D. The role of pharmacologically active microcarriers releasing TGF-beta 3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials 31, 6485, 2010.
6. Dickhut, A., Pelttari, K., Janicki, P., Wagner, W., Eckstein, V., Egermann, M., and Richter, W. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol 219, 219, 2009.
7. Schmitt, B., Ringe, J., Haupl, T., Notter, M., Manz, R., Burmester, G.R., Sittinger, M., and Kaps, C. BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation 71, 567, 2003.
8. Majumdar, M.K., Wang, E., and Morris, E.A. BMP-2 and BMP-9 promote chondrogenic differentiation of human multipotential mesenchymal cells and overcome the inhibitory effect of IL-1. J Cell Physiol 189, 275, 2001.
9. Huang, A.H., Motlekar, N.A., Stein, A., Diamond, S.L., Shore, E.M., and Mauck, R.L. High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann Biomed Eng 36, 1909, 2008.
10. Sellers, R.S., Peluso, D., and Morris, E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg-Am Vol 79A, 1452, 1997.
11. Yang, H.S., La, W.G., Bhang, S.H., Kim, H.J., Im, G.I., Lee, H., Park, J.H., and Kim, B.S. Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery. Tissue Eng Part A 17, 1809, 2011.
12. Shen, B.J., Wei, A.Q., Tao, H.L., Diwan, A.D., and Ma, D.D.F. BMP-2 enhances TGF-beta-3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 15, 1311, 2009.
13. You, M.L., Peng, G.F., Li, J.A., Ma, P., Wang, Z.H., Shu, W.L., Peng, S.W., and Chen, G.Q. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials 32, 2305, 2011.
14. Salinas, C.N., and Anseth, K.S. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 29, 2370, 2008.
15. Salinas, C.N., and Anseth, K.S. Decorin moieties tethered into PEG networks induce chondrogenesis of human mesenchymal stem cells. J Biomed Mater Res Part A 90A, 456, 2009.
16. Lee, H.J., Yu, C., Chansakul, T., Hwang, N.S., Varghese, S., Yu, S.M., and Elisseeff, J.H. Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-mediated microenvironment. Tissue Eng Part A 14, 1843, 2008.
17. Bahney, C.S., Hsu, C.W., Yoo, J.U., West, J.L., and Johnstone, B. A bioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB J 25, 1486, 2011.
18. Benoit, D.S.W., Schwartz, M.P., Durney, A.R., and Anseth, K.S. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 7, 816, 2008.
19. Saito, A., Suzuki, Y., Ogata, S., Ohtsuki, C., and Tanihara, M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. BBA-Proteins Proteomics 1651, 60, 2003.
20. Saito, A., Suzuki, Y., Kitamura, M., Ogata, S.I., Yoshihara, Y., Masuda, S., Ohtsuki, C., and Tanihara, M. Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alpha-tricalcium phosphate scaffold. J Biomed Mater Res Part A 77A, 700, 2006.
21. Moore, N.M., Lin, N.J., Gallant, N.D., and Becker, M.L. Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2-derived and RGD peptide concentration gradients. Acta Biomater 7, 2091, 2011.
22. He, X.Z., Ma, J.Y., and Jabbari, E. Effect of grafting RGD and BMP-2 protein-derived peptides to a hydrogel substrate on osteogenic differentiation of marrow stromal cells. Langmuir 24, 12508, 2008.
23. Niu, X.F., Feng, Q.L., Wang, M.B., Guo, X.D., and Zheng, Q.X. Preparation and characterization of chitosan micro- spheres for controlled release of synthetic oligopeptide derived from BMP-2. J Microencapsul 26, 297, 2009.
24. Cho, Y.J., Yeo, S.I., Park, J.W., Shin, H.I., Bae, Y.C., and Suh, J.Y. The effects of synthetic peptide derived from hBMP-2 on bone formation in rabbit calvarial defect. Tissue Eng Regen Med 5, 488, 2008.
25. Lee, J.S., Lee, J.S., and Murphy, W.L. Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater 6, 21, 2010.
26. Solchaga, L.A., Penick, K., Porter, J.D., Goldberg, V.M., Caplan, A.I., and Welter, J.F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203, 398, 2005.
27. Penick, K.J., Solchaga, L.A., and Welter, J.F. High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells. Biotechniques 39, 687, 2005.
28. Kim, Y.J., Sah, R.L.Y., Doong, J.Y.H., and Grodzinsky, A.J. Flourometic assay of DNA in cartilage explants using Hoechst-33258. Anal Biochem 174, 168, 1988.
29. Farndale, R.W., Buttle, D.J., and Barrett, A.J. Improved quantitation and discrimination of sufated glycosaminoglycans by use of dimethylemethylene blue. Biochim Biophys Acta 883, 173, 1986.
30. Woessner, J.F. Determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93, 440, 1961.
31. Salinas, C.N., Cole, B.B., Kasko, A.M., and Anseth, K.S. Chondrogenic differentiation potential of human mesenchymal stem cells photoencapsulated within poly(ethylene glycol)-arginine-glycine-aspartic acid-serine thiol-methacrylate mixed-mode networks. Tissue Eng 13, 1025, 2007.
32. Weiss, S., Hennig, T., Bock, R., Steck, E., and Richter, W. Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol 223, 84, 2010.
33. Wagner, D.R., Lindsey, D.P., Li, K.W., Tummala, P., Chandran, S.E., Smith, R.L., Longaker, M.T., Carter, D.R., and Beaupre, G.S. Hydrostatic pressure enhances chondrogenic differentiation of human bone marrow stromal cells in osteochondrogenic medium. Ann Biomed Eng 36, 813, 2008.
34. Pinhu, L., Park, J.E.S., Yao, W.X., and Griffiths, M.J.D. Reference gene selection for real-time polymerase chain reaction in human lung cells subjected to cyclic mechanical strain. Respirology 13, 990, 2008.
35. Bookout, A.L., Cummins, C.L., Mangelsdorf, D.J., Pesola, J.M., and Kramer, M.F. High-throughput real-time quantitative reverse transcription PCR. In: Current Protocols in Molecular Biology. New York: John Wiley & Sons, 2006, pgs. 15.8.1-15.8.28.
36. Mitchell, E.A., Chaffey, B.T., McCaskie, A.W., Lakey, J.H., and Birch, M.A. Controlled spatial and conformational display of immobilised bone morphogenetic protein-2 and osteopontin signalling motifs regulates osteoblast adhesion and differentiation in vitro. BMC Biol 8, 12, 2010.
37. Cahill, K.S., Chi, J.H., Day, A., and Claus, E.B. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA-J Am Med Assoc 302, 58, 2009.
38. Shields, L.B.E., Raque, G.H., Glassman, S.D., Campbell, M., Vitaz, T., Harpring, J., and Shields, C.B. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31, 542, 2006.
39. Steinert, A.F., Proffen, B., Kunz, M., Hendrich, C., Ghivizzani, S.C., Noth, U., Rethwilm, A., Eulert, J., and Evans, C.H. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11, 15, 2009.
40. Poole, A.R., Kojima, T., Yasuda, T., Mwale, F., Kobayashi, M., and Laverty, S. Composition and structure of articular cartilage - a template for tissue repair. Clin Orthop Rel Res 391, S26, 2001.
41. Nguyen, L.H., Kudva, A.K., Guckert, N.L., Linse, K.D., and Roy, K. Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials 32, 1327, 2011.
42. Ng, K.W., Ateshian, G.A., and Hung, C.T. Zonal chondrocytes seeded in a layered agarose hydrogel create engineered cartilage with depth-dependent cellular and mechanical inhomogeneity. Tissue Eng Part A 15, 2315, 2009.
43. Sharma, B., Williams, C.G., Kim, T.K., Sun, D.N., Malik, A., Khan, M., Leong, K., and Elisseeff, J.H. Designing zonal organization into tissue-engineered cartilage. Tissue Eng 13, 405, 2007.